Sihuan Pharmaceutical Holdings Group (TEL1) Stock Statistics & Valuation Metrics

Sihuan Pharmaceutical Holdings Group has a market cap or net worth of EUR 874.42M. The enterprise value is EUR 6.90B.

Market Cap

EUR 874.42M

Enterprise Value

EUR 6.90B

Sihuan Pharmaceutical Holdings Group has 9,329,999,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

9,329,999,000

Owned by Insiders

―

Owned by Institutions

5.12%

Sihuan Pharmaceutical Holdings Group’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 3.28%.

Return on Equity (ROE)

0.03

Return on Assets (ROA)

0.02

Return on Invested Capital (ROIC)

3.28%

Return on Capital Employed (ROCE)

0.08

Revenue Per Employee

920.86K

Profits Per Employee

63.21K

Employee Count

2,843

Asset Turnover

0.22

Inventory Turnover

0.98

The current PE Ratio of Sihuan Pharmaceutical Holdings Group is 20.50. Sihuan Pharmaceutical Holdings Group’s PEG ratio is 0.03.

PE Ratio

20.50

PS Ratio

2.34

PB Ratio

1.01

Price to FCF

-65.33

Price to Operating Cash Flow

-387.18

PEG Ratio

0.03

In the last 12 months, Sihuan Pharmaceutical Holdings Group had revenue of 2.62B and earned 179.70M in profits. Earnings per share was 0.02.

Revenue

2.62B

Gross Profit

1.80B

Operating Income

607.12M

Pretax Income

417.16M

Net Income

179.70M

EBITDA

702.00M

Earnings Per Share (EPS)

0.02

In the last 12 months, operating cash flow was -15.97M and capital expenditures -78.33M, giving a free cash flow of -94.29M billion.

Operating Cash Flow

-15.97M

Free Cash Flow

-94.29M

Free Cash Flow per Share

-0.01

Sihuan Pharmaceutical Holdings Group pays an annual dividend of ―, resulting in a dividend yield of 1.13%

Dividend Per Share

―

Dividend Yield

1.13%

Payout Ratio

N/A

Free Cash Flow Yield

-1.53%

Earnings Yield

4.88%

Beta

0.43

52-Week Price Change

-43.13%

50-Day Moving Average

0.08

200-Day Moving Average

0.11

Relative Strength Index (RSI)

69.17

Average Volume (3m)

―

Sihuan Pharmaceutical Holdings Group upcoming earnings date is Apr 01, 2027, TBA (Not Confirmed).

Last Earnings Date

Aug 26, 2026

Next Earnings Date

Apr 01, 2027

Ex-Dividend Date

―

Sihuan Pharmaceutical Holdings Group as a current ratio of 1.80, with Debt / Equity ratio of 17.20%

Current Ratio

1.80

Quick Ratio

1.58

Debt to Market Cap

0.09

Net Debt to EBITDA

-3.64

Interest Coverage Ratio

3.01

In the past 12 months, Sihuan Pharmaceutical Holdings Group has paid 231.75M in taxes.

Income Tax

231.75M

Effective Tax Rate

0.56

Sihuan Pharmaceutical Holdings Group EV to EBITDA ratio is 5.60, with an EV/FCF ratio of -41.44.

EV to Sales

1.48

EV to EBITDA

5.60

EV to Free Cash Flow

-41.44

EV to Operating Cash Flow

-244.71

Sihuan Pharmaceutical Holdings Group has EUR 3.72B in cash and marketable securities with EUR 969.22M in debt, giving a net cash position of EUR 2.75B billion.

Cash & Marketable Securities

EUR 3.72B

Total Debt

EUR 969.22M

Net Cash

EUR 2.75B

Net Cash Per Share

EUR 0.29

Tangible Book Value Per Share

EUR 0.66

Gross margin is 65.56%, with operating margin of 24.92%, and net profit margin of 11.46%.

Gross Margin

65.56%

Operating Margin

24.92%

Pretax Margin

23.78%

Net Profit Margin

11.46%

EBITDA Margin

26.49%

EBIT Margin

18.46%

The average price target for Sihuan Pharmaceutical Holdings Group is EUR 0.13, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target

EUR 0.13

Price Target Upside

40.27% Upside

Analyst Consensus

Moderate Buy

Analyst Count

1

Revenue Growth Forecast

20.62%

EPS Growth Forecast

―